It's very difficult for any major institution to not have problems similar to this, as there will always be individuals in positions of power who take it upon themselves to make decisions that can be construed as corrupt.
However, the fact this issue was revealed to the public, reported widely and also found to be a highly dubious shows the institute is working fine.
They appear to have systems and processes in place to help stop these kinds of dubious decisions, and because of the blowback from this rather poor decision, I'm certain the people at the FDA working the next round of approvals will make sure they hold up to scrutiny, which will be stronger than ever.
FDA Warning Letters: your pharmaceutical manufacturing plant was found to have adulteration and QA issues (again). Your medication actually has other medications or precursor/intermediate chemicals in it (again). FDA's response: a wag of the finger (again). So you "fix" the issue the next time the FDA Boy Scout comes around. All set.
elcritch|2 years ago
jussij|2 years ago
financltravsty|2 years ago
Rinse and repeat.